Neuberger Berman Group
AGIO icon

Neuberger Berman Group’s Agios Pharmaceuticals AGIO Stock Holding History

Neuberger Berman Group’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-9,670
Closed -$317K – 1899
2021
Q4 		$317K Sell
9,670
-18,637
-66% -$750K ﹤0.01% 1703
2021
Q3 		$1.3M Sell
28,307
-4,665
-14% -$225K ﹤0.01% 1251
2021
Q2 		$1.81M Sell
32,972
-5,360
-14% -$300K ﹤0.01% 1199
2021
Q1 		$1.98M Sell
38,332
-1,201
-3% -$59.5K ﹤0.01% 1158
2020
Q4 		$1.71M Sell
39,533
-1,048
-3% -$41.4K ﹤0.01% 1140
2020
Q3 		$1.42M Sell
40,581
-8,810
-18% -$386K ﹤0.01% 1128
2020
Q2 		$2.64M Sell
49,391
-1,401
-3% -$64.9K ﹤0.01% 956
2020
Q1 		$1.8M Sell
50,792
-26,806
-35% -$1.24M ﹤0.01% 969
2019
Q4 		$3.71M Buy
77,598
+10,899
+16% +$412K ﹤0.01% 904
2019
Q3 		$2.16M Sell
66,699
-24,440
-27% -$1.01M ﹤0.01% 994
2019
Q2 		$4.55M Sell
91,139
-4,624
-5% -$247K 0.01% 872
2019
Q1 		$6.46M Sell
95,763
-167,853
-64% -$9.78M 0.01% 808
2018
Q4 		$12.2M Sell
263,616
-79,775
-23% -$4.92M 0.02% 700
2018
Q3 		$26.5M Buy
343,391
+5,036
+1% +$405K 0.03% 563
2018
Q2 		$28.5M Buy
338,355
+103,415
+44% +$9.02M 0.03% 549
2018
Q1 		$19.2M Buy
234,940
+218,730
+1,349% +$16.9M 0.02% 642
2017
Q4 		$927K Buy
+16,210
New +$1.02M ﹤0.01% 1232
2015
Q2 		– Sell
-7,865
Closed -$742K – 1557
2015
Q1 		$742K Buy
7,865
+5,549
+240% +$622K ﹤0.01% 1265
2014
Q4 		$259K Buy
+2,316
New +$207K ﹤0.01% 1487

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Neuberger Berman Group's AGIO Position: Q1 2022 in Review

Neuberger Berman Group sold out of Agios Pharmaceuticals (AGIO) in Q1 2022, closing a stake of 9,670 shares — an estimated $317K sold.

Neuberger Berman Group first reported a position in AGIO in Q4 2014 and held it in 19 quarters. The position peaked at $28.5M in Q2 2018. 161 funds tracked by Wall St. Rank hold AGIO as of Q1 2022.

  • Neuberger Berman Group reported no remaining Agios Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Neuberger Berman Group sold 9,670 Agios Pharmaceuticals shares in Q1 2022, an estimated $317K.
  • Neuberger Berman Group first reported a position in Agios Pharmaceuticals in Q4 2014 and held it in 19 quarters.
  • Neuberger Berman Group's Agios Pharmaceuticals position peaked at $28.5M in Q2 2018.
  • 161 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2022.

Based on Neuberger Berman Group's 13F filing for Q1 2022, filed 13 May 2022.